Blueprint Medicines (BPMC)
(Real Time Quote from BATS)
$94.45 USD
-0.34 (-0.36%)
Updated Mar 28, 2024 09:36 AM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -1.65 |
EPS Last Quarter | -1.82 |
Last EPS Surprise | 10.78% |
ABR | 1.94 |
Earnings ESP
|
-9.36% |
---|---|
Current Year | -5.42 |
Next Year | -2.95 |
EPS (TTM) | -8.36 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 82.26M | 93.31M | 392.28M | 561.25M |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 86.70M | 101.90M | 424.60M | 618.20M |
Low Estimate | 78.10M | 88.30M | 371.76M | 504.03M |
Year ago Sales | 63.29M | 57.57M | 249.38M | 392.28M |
Year over Year Growth Est. | 29.97% | 62.09% | 57.30% | 43.07% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.65 | -1.43 | -5.42 | -2.95 |
# of Estimates | 10 | 9 | 10 | 10 |
Most Recent Consensus | -1.80 | -1.56 | -5.97 | -3.31 |
High Estimate | -1.45 | -1.22 | -4.30 | -1.74 |
Low Estimate | -1.80 | -1.63 | -6.35 | -4.30 |
Year ago EPS | -2.15 | -2.19 | -8.37 | -5.42 |
Year over Year Growth Est. | 23.26% | 34.70% | 35.24% | 45.55% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 4 | 3 | 5 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 3 | 5 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.65 | -1.43 | -5.42 | -2.95 |
7 Days Ago | -1.65 | -1.43 | -5.42 | -2.95 |
30 Days Ago | -1.67 | -1.47 | -5.58 | -3.14 |
60 Days Ago | -1.74 | -1.45 | -5.44 | -3.08 |
90 Days Ago | -1.79 | -1.52 | -5.70 | -3.59 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.80 | -1.56 | -5.97 | -3.31 |
Zacks Consensus Estimate | -1.65 | -1.43 | -5.42 | -2.95 |
Earnings ESP | -9.36% | -9.18% | -10.17% | -12.20% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.82 | -2.20 | -2.19 | -2.15 | NA |
Estimate | -2.04 | -2.39 | -2.58 | -2.66 | NA |
Difference | 0.22 | 0.19 | 0.39 | 0.51 | 0.33 |
Surprise | 10.78% | 7.95% | 15.12% | 19.17% | 13.26% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more